Comprehensive Capabilities To Successfully Lead Development And Manufacturing Projects For Highly Potent Active Pharmaceutical Ingredients

On December 9, 2021, a special lecture was given on the theme of “Development and Scale-up of Highly Potent Active Ingredients” at Inpharma Japan, held at Makuhari Messe. Michiya Hayakawa of Lonza Corporation gave an overview of the current market environment and presented strategies for manufacturing highly potent active drugs for which demand is increasing, as well as key points for promoting projects that utilize special formulation technologies.

This article explores how the global pharmaceutical market is changing and HPAPI considerations. An ADC payload linker that enables fast and flexible manufacturing planning is also discussed.